Global New Medical Biomaterials 麻豆原创 2025 by Company, Regions, Type and Application, Forecast to 2031

Publication ID:

GIR022505376

Publication Date:

February 18, 2025

Pages:

113

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global New Medical Biomaterials market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global New Medical Biomaterials market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global New Medical Biomaterials market size and forecasts, in consumption value ($ Million), 2020-2031
Global New Medical Biomaterials market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global New Medical Biomaterials market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global New Medical Biomaterials market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for New Medical Biomaterials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global New Medical Biomaterials market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Invibio, STR, Avitus, Sagemax, Stratasys, Formlab, TeraPore Technologies, NanoH2O (LG), Secant Medical, Covalent-coating, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
New Medical Biomaterials market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Metallic Material
Bio-ceramic
Polymer Materials
Composites
Others
麻豆原创 segment by Application
Packaging
Transplant components
Dental products
Catheters
Other
麻豆原创 segment by players, this report covers
Invibio
STR
Avitus
Sagemax
Stratasys
Formlab
TeraPore Technologies
NanoH2O (LG)
Secant Medical
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe New Medical Biomaterials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of New Medical Biomaterials, with revenue, gross margin, and global market share of New Medical Biomaterials from 2020 to 2025.
Chapter 3, the New Medical Biomaterials competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and New Medical Biomaterials market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of New Medical Biomaterials.
Chapter 13, to describe New Medical Biomaterials research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of New Medical Biomaterials by Type
1.3.1 Overview: Global New Medical Biomaterials 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global New Medical Biomaterials Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Metallic Material
1.3.4 Bio-ceramic
1.3.5 Polymer Materials
1.3.6 Composites
1.3.7 Others
1.4 Global New Medical Biomaterials 麻豆原创 by Application
1.4.1 Overview: Global New Medical Biomaterials 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Packaging
1.4.3 Transplant components
1.4.4 Dental products
1.4.5 Catheters
1.4.6 Other
1.5 Global New Medical Biomaterials 麻豆原创 Size & Forecast
1.6 Global New Medical Biomaterials 麻豆原创 Size and Forecast by Region
1.6.1 Global New Medical Biomaterials 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global New Medical Biomaterials 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America New Medical Biomaterials 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe New Medical Biomaterials 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific New Medical Biomaterials 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America New Medical Biomaterials 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa New Medical Biomaterials 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Invibio
2.1.1 Invibio Details
2.1.2 Invibio Major Business
2.1.3 Invibio New Medical Biomaterials Product and Solutions
2.1.4 Invibio New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Invibio Recent Developments and Future Plans
2.2 STR
2.2.1 STR Details
2.2.2 STR Major Business
2.2.3 STR New Medical Biomaterials Product and Solutions
2.2.4 STR New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 STR Recent Developments and Future Plans
2.3 Avitus
2.3.1 Avitus Details
2.3.2 Avitus Major Business
2.3.3 Avitus New Medical Biomaterials Product and Solutions
2.3.4 Avitus New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Avitus Recent Developments and Future Plans
2.4 Sagemax
2.4.1 Sagemax Details
2.4.2 Sagemax Major Business
2.4.3 Sagemax New Medical Biomaterials Product and Solutions
2.4.4 Sagemax New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Sagemax Recent Developments and Future Plans
2.5 Stratasys
2.5.1 Stratasys Details
2.5.2 Stratasys Major Business
2.5.3 Stratasys New Medical Biomaterials Product and Solutions
2.5.4 Stratasys New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Stratasys Recent Developments and Future Plans
2.6 Formlab
2.6.1 Formlab Details
2.6.2 Formlab Major Business
2.6.3 Formlab New Medical Biomaterials Product and Solutions
2.6.4 Formlab New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Formlab Recent Developments and Future Plans
2.7 TeraPore Technologies
2.7.1 TeraPore Technologies Details
2.7.2 TeraPore Technologies Major Business
2.7.3 TeraPore Technologies New Medical Biomaterials Product and Solutions
2.7.4 TeraPore Technologies New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 TeraPore Technologies Recent Developments and Future Plans
2.8 NanoH2O (LG)
2.8.1 NanoH2O (LG) Details
2.8.2 NanoH2O (LG) Major Business
2.8.3 NanoH2O (LG) New Medical Biomaterials Product and Solutions
2.8.4 NanoH2O (LG) New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 NanoH2O (LG) Recent Developments and Future Plans
2.9 Secant Medical
2.9.1 Secant Medical Details
2.9.2 Secant Medical Major Business
2.9.3 Secant Medical New Medical Biomaterials Product and Solutions
2.9.4 Secant Medical New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Secant Medical Recent Developments and Future Plans
2.10 Covalent-coating
2.10.1 Covalent-coating Details
2.10.2 Covalent-coating Major Business
2.10.3 Covalent-coating New Medical Biomaterials Product and Solutions
2.10.4 Covalent-coating New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Covalent-coating Recent Developments and Future Plans
2.11 Nasseo
2.11.1 Nasseo Details
2.11.2 Nasseo Major Business
2.11.3 Nasseo New Medical Biomaterials Product and Solutions
2.11.4 Nasseo New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Nasseo Recent Developments and Future Plans
2.12 TriboFilm
2.12.1 TriboFilm Details
2.12.2 TriboFilm Major Business
2.12.3 TriboFilm New Medical Biomaterials Product and Solutions
2.12.4 TriboFilm New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 TriboFilm Recent Developments and Future Plans
2.13 ACS material
2.13.1 ACS material Details
2.13.2 ACS material Major Business
2.13.3 ACS material New Medical Biomaterials Product and Solutions
2.13.4 ACS material New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 ACS material Recent Developments and Future Plans
2.14 Palmaz Scientific
2.14.1 Palmaz Scientific Details
2.14.2 Palmaz Scientific Major Business
2.14.3 Palmaz Scientific New Medical Biomaterials Product and Solutions
2.14.4 Palmaz Scientific New Medical Biomaterials Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Palmaz Scientific Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global New Medical Biomaterials Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of New Medical Biomaterials by Company Revenue
3.2.2 Top 3 New Medical Biomaterials Players 麻豆原创 Share in 2024
3.2.3 Top 6 New Medical Biomaterials Players 麻豆原创 Share in 2024
3.3 New Medical Biomaterials 麻豆原创: Overall Company Footprint Analysis
3.3.1 New Medical Biomaterials 麻豆原创: Region Footprint
3.3.2 New Medical Biomaterials 麻豆原创: Company Product Type Footprint
3.3.3 New Medical Biomaterials 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global New Medical Biomaterials Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global New Medical Biomaterials 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global New Medical Biomaterials Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global New Medical Biomaterials 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America New Medical Biomaterials Consumption Value by Type (2020-2031)
6.2 North America New Medical Biomaterials 麻豆原创 Size by Application (2020-2031)
6.3 North America New Medical Biomaterials 麻豆原创 Size by Country
6.3.1 North America New Medical Biomaterials Consumption Value by Country (2020-2031)
6.3.2 United States New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe New Medical Biomaterials Consumption Value by Type (2020-2031)
7.2 Europe New Medical Biomaterials Consumption Value by Application (2020-2031)
7.3 Europe New Medical Biomaterials 麻豆原创 Size by Country
7.3.1 Europe New Medical Biomaterials Consumption Value by Country (2020-2031)
7.3.2 Germany New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific New Medical Biomaterials Consumption Value by Type (2020-2031)
8.2 Asia-Pacific New Medical Biomaterials Consumption Value by Application (2020-2031)
8.3 Asia-Pacific New Medical Biomaterials 麻豆原创 Size by Region
8.3.1 Asia-Pacific New Medical Biomaterials Consumption Value by Region (2020-2031)
8.3.2 China New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America New Medical Biomaterials Consumption Value by Type (2020-2031)
9.2 South America New Medical Biomaterials Consumption Value by Application (2020-2031)
9.3 South America New Medical Biomaterials 麻豆原创 Size by Country
9.3.1 South America New Medical Biomaterials Consumption Value by Country (2020-2031)
9.3.2 Brazil New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa New Medical Biomaterials Consumption Value by Type (2020-2031)
10.2 Middle East & Africa New Medical Biomaterials Consumption Value by Application (2020-2031)
10.3 Middle East & Africa New Medical Biomaterials 麻豆原创 Size by Country
10.3.1 Middle East & Africa New Medical Biomaterials Consumption Value by Country (2020-2031)
10.3.2 Turkey New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE New Medical Biomaterials 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 New Medical Biomaterials 麻豆原创 Drivers
11.2 New Medical Biomaterials 麻豆原创 Restraints
11.3 New Medical Biomaterials Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 New Medical Biomaterials Industry Chain
12.2 New Medical Biomaterials Upstream Analysis
12.3 New Medical Biomaterials Midstream Analysis
12.4 New Medical Biomaterials Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Invibio
STR
Avitus
Sagemax
Stratasys
Formlab
TeraPore Technologies
NanoH2O (LG)
Secant Medical
Covalent-coating
Nasseo
TriboFilm
ACS material
Palmaz Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.